# CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial

> **NCT06886113** · NA · NOT_YET_RECRUITING · sponsor: **Shenzhen Core Medical Technology CO.,LTD.** · enrollment: 269 (estimated)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DEVICE:** Conventional circulatory support
- **DEVICE:** CorVad

## Key facts

- **NCT ID:** NCT06886113
- **Lead sponsor:** Shenzhen Core Medical Technology CO.,LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2028-02-15
- **Target enrollment:** 269 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06886113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06886113, "CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT06886113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*